nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

  • (91) 00000-00000
  • Social Networking

Ranbaxy Laboratories Limited (NSE India Code : RANBAXY)       BUY

Company Name :
 NSE SYMBOL :  
Enter Company Name or NSE Code

RANBAXY Technical Levels

Resistance 2 550.50
Resistance 1 544.75
PIVOT 540.75
Support 1 535.00
Support 2 525.25

RANBAXY Fundamentals

Earning Growth 99.99%
Profit Margin -2.51
PE -99.99
EPS -2.84
Quarter 30-Sep-11

RANBAXY Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size 500

RANBAXY Options

Most Active Call 540
Most Active Put 480
Highest OI Call 540
Highest OI Put 520
Expiry Date 19-Oct-12

RANBAXY Technical Levels


Other Stocks from Pharmaceuticals Sector  AARTIDRUGS   ABBOTINDIA   AJANTPHARM   ALCHEM   ALKALI   ALPA   AMRUTANJAN   ANKURDRUGS   ARL   ASTRAZEN   AUROPHARMA   AVENTIS   BALPHARMA   BIOCON   BLISSGVS   CADILAHC   CELESTIAL   CIPLA   DISHMAN   DIVISLAB   DRREDDY   ELDERPHARM   FDC   FKONCO   GLAXO   GLENMARK   GRANULES   INDOCO   INDSWFTLAB   INDSWFTLTD   IPCALAB   JAGSNPHARM   JBCHEPHARM   JUBILANT   KILITCH   KOPRAN   LUPIN   LYKALABS   MANGALAM   MERCK   MOREPENLAB   NATCOPHARM   NECLIFE   NEULANDLAB   OPTOCIRCUI   ORCHIDCHEM   PANACEABIO   PARABDRUGS   PFIZER   PIRHEALTH 

Sponsored Advertisement

RANBAXY Share Price on 5-10-2012

Open 535
High 538
Low 498.3
Close 529.4
Volume 734076
Change -5.25 (-0.98%)
Series EQ
Date of Listing 28-Jun-95
Paid Up Value 5
Face Value 5
Market Capital 8123.99 Crores
52 Week High/Low 578.4 / 365.5
Sponsored Advertisement

Ranbaxy Laboratories Limited Company Profile

Ranbaxy Laboratories manufactures and markets pharmaceutical dosage forms (for human health care), animal health care products, bulk drugs and intermediates, diagnostics, laboratory chemicals and reagents. It is the largest exporter of bulk drugs and pharmaceutical dosage forms in India. Incorporated in 1961, the company went public in 1973. The company has manufacturing operations in eight countries with a ground presence in 49 countries, and its products are available in over 125 countries. Ranbaxy made an acquisition of RPG Aventis, France which has since been renamed as Ranbaxy Pharmacie Generiques SAS. Laboratorios Ranbaxy was incorporated in Barcelona, Spain as a wholly-owned subsidiary of Ranbaxy Netherlands. Ranbaxy Australia was set up in Sydney as a wholly-owned subsidiary of Ranbaxy Netherlands. ZAO Ranbaxy was incorporated in Moscow, Russia as a wholly-owned subsidiary of Ranbaxy Netherlands. Ranbaxy has Thembalami Pharmaceuticals as its JV. The Group acquired Terapia SA, Ranbaxy Belgium NV, Mundogen Pharma SA, Substantial assets of Allen SpA and Be-Tabs Pharmaceuticals. The company has decided to lay greater thrust in the areas of novel drug delivery systems and new drug discovery research, enhance emphasis on custom synthesis to draw greater leverage on built-in chemical and clinical research.

RANBAXY Intraday Realtime Chart

RANBAXY Corporate Announcements

DATE PURPOSE
03-Aug-12 Press Release
11-Jul-12 Allotment of Securities
20-Jun-12 Press Release
28-May-12 Press Release
21-May-12 Audit Qualifications/Comments

RANBAXY Corporate Actions

DATE PURPOSE
26-Apr-12 Annual General Meeting
26-Apr-12 Annual General Meeting
28-Apr-11 DIVIDEND-RS.2 PER SHARE
28-Apr-11 Dividend - Rs. 2 Per Share

RANBAXY Board Meetings

MEETING DATE PURPOSE
09-Aug-12 Un-audited Financial Results
09-May-12 Un-audited Financial Results
23-Feb-12 Audited Financial Results
09-Nov-11 Un-audited Financial Results
05-Aug-11 Un-audited Financial Results

RANBAXY Related companies

Symbol Company Name
AARTIDRUGS Aarti Drugs Limited
ABBOTINDIA Abbott India Limited
AJANTPHARM Ajanta Pharma Limited
ALCHEM Alchemist Limited
ALKALI Alkali Metals Limited

Most Active NSE INDIA Stocks

 HDFC   LITL   IVRCLINFRA   HDIL   UNITECH   JPASSOCIAT   GVKPIL   TATAMOTORS   IFCI   IBREALEST   ESSAROIL   GMRINFRA   BIRLAPOWER   HINDALCO   BHEL   RENUKA   RCOM   DLF   SUZLON   RELCAPITAL   IDFC   ADANIENT   ITC   TATAPOWER   BALLARPUR 

Free Stock Market Tips:
What are the eligibility criteria for members of the currency futures segment?

VJonDalalStreet Paid Tips

Home
Stock Market IPO
Mutual Funds
Education Paid Service
About us
Share Market
IPO Watch
MF News
IPO
Subscription
VJonDalalStreet
Technical Analysis
New IPO Review
Old Funds
Articles
Equity Performance
DalalStreet Blog
Stock Market News Indian IPO News
New Funds
Stock Market
Futures Performance
Free Sms Alerts
World Stock Market
IPO Allotment Status
Best Funds
Financial Terms
Options Performance
Privacy Stock Recommendations
Grey Market Premium MF Analysis Futures & Options Jackpot Performance
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer
Follow VJonDalalStreet on Facebook Follow VJonDalalStreet on Twitter Follow VJonDalalStreet Blog Email VJonDalalStreet